Ypsomed

Ypsomed is a Swiss-based developer and manufacturer of devices for self administration of insulin (e.g. pens). In 2018, the company decided to reshore to Switzerland the production of insulin pens it had been outsourced and offshored in Mexico in the '80. The reshoring decision was implemented after huge investments in technology; among them, the adoption of automated production process - within the company and its suppliers - and the digitalization of selected production processes through the 5G telecommunication technology (realized in partnership with Swisscom). These technologies allowed simpler, safer, and more efficient processes, increasing company's flexibility and reducing production costs.